We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




A Fifth of Stroke Survivors Fail to Take Antithrombotic Medication

By HospiMedica International staff writers
Posted on 28 Dec 2009
A new study claims that approximately 20% of stroke survivors are not taking antithrombotic agents such as aspirin, despite doctor's recommendations. More...


Researchers at the University of California, Los Angeles (UCLA; USA) analyzed data compiled from seven U.S. annual medical-expenditure panel survey (MEPS) data sets, from 2000 to 2006, in which 4,168 people reported having had a stroke. The study authors then looked at the participant's use of antithrombotic agents, which include aspirin, other antiplatelet medications, and anticoagulants. Pooling the results across the seven years, the researchers found that 75% of the stroke survivors were using an antithrombotic agent, with 66% reporting taking antiplatelet medication, and 57% taking aspirin. After excluding those individuals who reported not taking aspirin because it was unsafe for them, the researchers calculated that 81% were actually using their antithrombotic agents. The researchers also found that individuals who were younger, female, or of Hispanic origin were less likely to take their medication. The findings were published in the January 2010 issue of the American Journal of Preventive Medicine.

"Even though use of prescription antiplatelet medications is rising, aspirin remains the predominant antithrombotic agent used for secondary stroke prevention. There were no improvements in overall use of antithrombotic agents over the 7-year period,” said lead author assistant professor of neurology Eric Cheng, M.D., M.S. "Use of aspirin, prescription antiplatelet agents, and use of any antiplatelet agent increased over the study period, but after dropping the first 2 years, no temporal trend was detected, indicating that temporal changes in usage of these agents had plateaued.”

The annual MEPS survey contains data on use of both aspirin and other prescription medications. Each year, a MEPS panel is drawn from respondents from the previous year's U.S. National Health Interview Survey, a representative sample of the U.S. civilian noninstitutionalized population, with oversampling of minority populations and households with low family income.

Related Links:
University of California, Los Angeles


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Immobilization System
Cranial 4Pi Immobilization
New
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.